Rapport

The Operational Impact of Switching from a Two-Dose to a One-Dose HPV Vaccination Schedule: Lessons Learned from Burkina Faso, Ethiopia, and Solomon Islands

HAPPI

PATH conducted a study on behalf of the HPV Vaccine Acceleration Program Partners Initiative (HAPPI) Consortium to obtain insights into how switching to a single-dose schedule has impacted HPV vaccination programs in low- and middle-income countries and to gather insights for ongoing program planning and sustainability with a single-dose schedule. PATH conducted 35 semi-structured key informant interviews with national and subnational stakeholders in Burkina Faso, Ethiopia, and Solomon Islands to explore the operational aspects of switching from a two-dose to a one-dose HPV vaccination schedule across key thematic areas of the immunization program. This report shares high-level results from the study.

Auteurs

Langues

  • Anglais

Année de publication

2025

Type

Rapport

Catégories

  • Gestion de programme

Maladies

  • Papillomavirus humain

Pays

  • Burkina Faso
  • Éthiopie
  • Îles Salomon

Organisations

  • JSI
  • PATH

Mots-clés

  • Présentation et emballage des vaccins

HPV-INTRO-SINGLE

Cette ressource est incluse dans le tableau suivant:

TitreAuteurAnnéeTypeLangue
Review of Existing Evidence on Single-Dose HPV VaccinationSingle dose consortium2022PresentationAnglais, Français
HPV VACCINE SCHEDULE OPTIMIZATION Key considerations for decision-making, planning, and implementationPATH, JSI, UNICEF, Gavi, the Vaccine Alliance, Clinton Health Access Initiative (CHAI), Jhpiego, International Vaccine Access Center (IVAC), Centers for Disease Control and Prevention (CDC), John Hopkins Bloomberg School of Public Health2023GuidanceAnglais, Français, Portuguais, Russe, Espagnol
Considerations for Human Papillomavirus (HPV) Vaccine Product Choice: Second EditionWorld Health Organization (WHO)2024GuidanceAnglais
The Operational Impact of Switching from a Two-Dose to a One-Dose HPV Vaccination Schedule: Lessons Learned from Burkina Faso, Ethiopia, and Solomon Islands HAPPI2025ReportAnglais

PORTFOLIO-LESSONS

Cette ressource apparaît sur le Thème suivant:

Cette ressource est incluse dans le tableau suivant:

TitreAuteurAnnéeTypeLangue
The switch from ROTARIX to ROTAVAC in Ghana: Answers to four key questionsPATH2022ReportAnglais
The Health Benefits of Rotavirus Immunization for Children in Palestine: Results of a Vaccine Impact AnalysisPATH, Rostropovich-Vishnevskaya Foundation, Palestine Ministry of Health2021ReportRusse
Economic Implications of Switching Rotavirus Vaccine Products in Palestine's Immunization ProgramPATH2020Case studyArabe, Anglais, Russe, Français
Introducing 5-dose Measles-Rubella Vaccine Vials in Zambia: Research FindingsDose Per Container Partnership (DPCP), JSI2019Case studyAnglais
The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in ZambiaKirstin Krudwig, Barbara Knittel, Ali Karim, Natasha Kanagat, Wendy Prosser, Guissimon Phiri, Frances Mwansa, Robert Steinglass2020Journal articleAnglais
A Switch for Sustainability in Ghana's Rotavirus Vaccine ProgramGeorge Armah2020Case studyAnglais
The Operational Impact of Switching from a Two-Dose to a One-Dose HPV Vaccination Schedule: Lessons Learned from Burkina Faso, Ethiopia, and Solomon Islands HAPPI2025ReportAnglais
Economic implications of switching to the hexavalent infant vaccine in an immunization program in IndiaPawan Kumar, Kapil Singh, Arindam Ray, Arup Deb Roy, Susmita Chatterjee, Homero Hernandez, Amrita Kumari2026Journal articleAnglais

Ajouté par: HAPPI

Ajouté le: 2025-11-25 21:02:35

Consultations: 667

Liens

Fichier téléchargé

Impact of Switching to a Single Dose Schedule.pdf

Cliquez pour télécharger

Ajouter une ressource